This interview with Dr. Mohammad S Safiarian, Associate Product Manager at Sino Biological, discusses the advances in influenza research and how effective vaccines are developed.
Mydecine Innovations Group Inc Provides Bi-Weekly Status Report | Psychedelic Invest
Vancouver, British Columbia, June 3, 2024- Mydecine Innovations Group Inc. (the “Company“) (CSE: MYCO) (FSE: 0NF0) (OTC: MYCOF) (AQSE: MYIG) provides this update on the status